Novo Nordisk announces new, cheaper Ozempic copy for SA

Novo Nordisk has announced the launch of a cheaper generic version of its drug Ozempic in South Africa, used for treating type 2 diabetes. This copy, priced lower than the original, aims to improve access to treatment for South African patients. The decision comes amid pressure on drug prices in the country.